Every one of those 1 sits in a single category, funding. Of the tracked stories, 1 of 1 also mention Sky Impact Capital, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6 for that window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Oncare
Every one of those 1 sits in a single category, funding. Of the tracked stories, 1 of 1 also mention Sky Impact Capital, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6 for that window. They are less corroborated than the beat average, carrying 2 original sources each against 2.4 for the same window. We currently track 1 Healthcare story that mention Oncare, all published on February 24, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 26 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Oncare. Shared-story counts are live from our verified record — not editorial picks.
Oncology startup Oncare has raised ₹27 crore ($3 million) in a Series A round led by Sky Impact Capital to scale its specialized clinic network. The funding will facilitate expansion from Delhi NCR into metro and Tier-2/3 cities, addressing critical gaps in accessible cancer treatment.